First EU JCA Insights: Early Learnings for Navigating a Harmonized Access Landscape

The first EU Joint Clinical Assessment (JCA) is now published, marking a pivotal new milestone for both the pharmaceutical industry and Healthcare Authorities in Europe.Looking at the first report (tovorafenib in pediatric low‑grade glioma), one [...]

By |2026-07-13T11:51:14+01:00June 11th, 2026|WEP Insights|

From Reactive to Proactive: Building Resilient, Human-Centered Hybrid Clinical Trials

Hybrid and decentralized clinical trial models are often discussed in terms of technology: remote visits, telemedicine, wearable devices, home-based assessments, and digital data collection. While these capabilities are important, they only tell part of the [...]

By |2026-06-03T16:10:17+01:00June 3rd, 2026|WEP Insights|